(Q33698075)

28 July 2017

Monitoring influenza virus susceptibility to oseltamivir using a new rapid assay, iART (English)

1 reference

28 July 2017

1 reference

10

David E Wentworth

1 reference

28 July 2017

7

Alicia M Fry

1 reference

28 July 2017

0 references

1

Larisa V Gubareva

1 reference

28 July 2017

3

Vasiliy P Mishin

1 reference

28 July 2017

Eric Fallows

2

1 reference

28 July 2017

Erin Hodges

4

1 reference

28 July 2017

Abdullah Brooks

5

1 reference

28 July 2017

John Barnes

6

1 reference

28 July 2017

William Kramp

8

1 reference

28 July 2017

Roxanne Shively

9

1 reference

28 July 2017

Kristin Weidemaier

11

1 reference

28 July 2017

Ross Jacobson

12

1 reference

28 July 2017

1 May 2017

1 reference

28 July 2017

1 reference

28 July 2017

22

1 reference

28 July 2017

18

1 reference

Creative Commons Attribution 4.0 International

28 July 2017

start time

4 May 2017

1 reference

April 2023 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Emergence of Multidrug-Resistant Influenza A(H1N1)pdm09 Virus Variants in an Immunocompromised Child Treated With Oseltamivir and Zanamivir

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2012-2013.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Influenza virus resistance to neuraminidase inhibitors.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5434880

Evaluation of influenza virus antiviral susceptibility testing in Europe: results from the first external quality assessment exercise

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.2807%2F1560-7917.ES.2017.22.18.30529

Meetings of the WHO working group on surveillance of influenza antiviral susceptibility – Geneva, November 2011 and June 2012

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28494845

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2807/1560-7917.ES.2017.22.18.30529

1 reference

release_ddfinyqp5vax3n625oqj4jyqj4

28 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ddfinyqp5vax3n625oqj4jyqj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMCID

5434880

1 reference

28 July 2017

1 reference